Total Funding
31
68
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
176229
Senzagen offers animal-free testing of chemical compounds using genomics-based methodology for immunotoxicological assays.
- Malin Lindstedt: Founder
- Peter Nählstedt: President and Chief Executive OfficerPast Role: Probi, Chief Executive Officer
About the Company
Senzagen is a spin out company from Lund University with expertise in immunology, technology and genomics. SenzaGen markets, sells and performs the in vitro GARD sensitization test through its own laboratory and through licenced CROs.
It offers animal-free testing of chemical compounds using genomics-based methodology for immunotoxicological
assays. Their proprietary lead product family, GARD, potentially replaces the need for animal testing in the cosmetic, chemical and pharmaceutical industries.
